top of page
CLINICAL PRECISION

Data-Driven Prescribing.
Personalized Patient
Care.

Advanced pharmacogenomic profiling designed as a
seamless clinical decision support tool for high-complexity
healthcare environments.

Request PGx Consultation
Download Sample Report

Medication Insight

Patient ID: #ER-90210

IN PROGRESS

Warfarin (Coumadin)

HIGH SENSITIVITY

Clopidogrel (Plavix)

INTERMEDIATE

Sertraline (Zoloft)

NORMAL

Precision Across Therapeutic Areas

Understanding how genetic variants influence metabolism allows for proactive dose
adjustments and drug selection.

AB6AXuCK2zlgeYdUq393fP6bO65ym6uiSaxuM-xRRaD-lGGfE9O_B7MFmzHzmhhbQkJsyida9gcOTzqIeNzKYW1tetoEVOBP9L4XbbBGwkefHe2VyhFSbfYetXPLITL7GmGuJpmuVGwnVBD1XAPCN8SZSzwbGiiCEdaI3Ig1ZvJ8q6CCo6zZEfI9oo0iesneBbH8Qf-NJtH2IXGKvWmEjTkUe93ZTG6fpBB-veVIxYkiUSuwhgSfo8JOub3akQ

Cardiovascular Health

Reduce trial-and-error prescribing for anticoagulants and statins. Our PGx panel identifies
risks for CYP2C19 and VKORC1 variants.

ACCURACY

99.8%

VARIANTS

42

CLINICAL SENS.

High

Psychiatry

Optimizing SSRIs and antipsychotics
through CYP2D6 and CYP2C19
metabolism mapping.

AB6AXuAnZz5oRWbSka7aQvF2mNs_cgPAd90BxIASjw7b1Wd4L_hr38k2c-HjZnH3ZTLbQUm6ux0bao4mWV2pwwoybwqBzbAuflY3BRn1SmDdddt05ZE2FTHfR8H8x34G1VN7h0b7p5ep-l-vUau4YGE4E_vt-hQxM5Bqtn0JZaslzByOmNd78xBbBI8TxKht10sCDFZnljvPU_P19OoqZPcxUjTc1ojzRqK4geebLEF2rk2gZf9tzQmd6g6wsQ

Pain Management

Identifying genetic predisposition for
opioid metabolism to prevent adverse
effects and toxicity.

INTEGRATED DIAGNOSTICS

Comprehensive PGx Panel

Our 50+ gene panel covers the majority of FDA-cleared
and CPIC-level A/B medication associations across clinical
practice.

CYP2D6
CYP2C19
DPYD
UGT1A1
HLA-B*5701

Actionable Clinical Intelligence

Reports aren't just data—they're clear directions. Our Provider Portal
integrates results into actionable panels that highlight exactly which
medications require dosage adjustments or avoidance.

EMR/EHR Integration

Seamless PDF and HL7 data transfers into common provider
workflows.

CPIC Guided Recommendations

Guidelines from the Clinical Pharmacogenetics Implementation
Consortium built into every report.

Cardiovascular Panel

Results for Patient: J. Doe | DOB: 01/12/1978

STATUS

FINALIZED

DRUG CLASS

MEDICATION

ACTION

Antiplatelet

Clopidogrel

USE ALTERNATIVE

Anticoagulant

Warfarin

LOWER DOSE

Statin

Atorvastatin

STANDARD
Clinical Note: CYP2C19 Intermediate Metabolizer identified. Consider Ticagrelor or Prasugrel if clinically appropriate for acute coronary syndrome.

REPORT PREVIEW: PGX-COMPREHENSIVE

v2.1 Clinical Build

4

Reporting

Digital result delivery
within 3-5 business days.

3

Analysis

High-complexity NGS and
MassArray interpretation.

2

Logistics

Pre-paid overnight transit
to our COLA-accredited
facility.

1

Collection

Simple buccal swab or
blood draw in-office or at
home.

The Testing Lifecycle

AB6AXuDfbwcu9C4OUOruug5jDqvafqev6VBrt9yFNSoXgtSB-KGbwHBPeUJhMGytJHC1wMxGsrPqrfoL30VJ8jejC7x3Y02RNGBwsmdMrkeRi1Ihh-6ygcsqWshLg4pDIxg_L4d14SMHyoAk0rOT6kLsLBDTBX17x9pPPvep3WrNydKpJuZNiDtLA19SrN4rl_sErt1JV78QYCPTqqogkPtRgndN53oEgRntRA-r-fdYJohj6ldEwbKcsIUJFA

5,000+

Annual Tests Performed with
Clinical Oversight

Clinical Pharmacist Consultations

EnarroMDx provides more than just raw data. Every complex report is
available for review with our board-certified clinical pharmacists to ensure
optimal integration into the patient's care plan.

Peer-Reviewed Methodology: All testing follows strict CPIC and
PharmGKB evidence guidelines.

Expert Support: 1-on-1 consultations for complex polypharmacy
cases.

Schedule a Consult

Empower Your Practice with Precision

Join hundreds of leading medical groups across the country utilizing EnarroMDx for medication
safety and efficacy.

Request Testing Supplies
Download Clinical Catalog
bottom of page